AWH Announces Fourth Quarter and Full Year 2025 Results

Core Insights - Ascend Wellness Holdings, Inc. (AWH) reported Q4 2025 revenue of $120.5 million and full-year revenue of $500.6 million, reflecting a strategic focus on densification and profitability [1][2] - The company achieved an Adjusted EBITDA Margin of 25.1% in Q4 2025 and 23.4% for FY 2025, indicating improved operational efficiency [1][2] - AWH maintained strong liquidity with $85.7 million in cash and no significant near-term debt, positioning itself for future growth [1][2] Financial Performance - Q4 2025 total net revenue was $120.5 million, a 3.4% decline from Q3 2025, with retail revenue increasing by 1.4% to $85.0 million [2][3] - FY 2025 total net revenue was $500.6 million, a 10.9% year-over-year decline, with retail revenue at $339.6 million, down 8.8% from FY 2024 [2][3] - Gross profit for Q4 2025 was $45.1 million, or 37.4% of revenue, compared to $43.6 million, or 35.0% in Q3 2025 [2][3] Business Highlights - AWH executed a densification strategy, opening eight new dispensaries in 2025, expanding its retail footprint to 48 locations, with plans for 12 more [1][2] - The company launched a record 566 SKUs in FY 2025, exceeding its goal of 550, and introduced new brands and product formats [1][2] - AWH's e-commerce ecosystem was enhanced, with a 56% growth in loyalty program membership and a 49.4% increase in sales through Ascend Pay [1][2] Management Commentary - The CEO highlighted 2025 as a pivotal year, emphasizing progress in densification, profitability, and sustainability, with a target of 60 stores by the end of 2026 [2][3] - The CFO noted strengthened financial flexibility and liquidity, establishing a stable capital foundation for disciplined expansion [2][3] Outlook - For Q1 2026, AWH anticipates a low to mid-single digit decline in topline revenue due to post-holiday consumer softness and ongoing pricing pressures [3] - Despite these challenges, the company expects Adjusted EBITDA Margin to remain in the low-20% range, supported by new store openings and commercialization of higher-margin SKUs [3]

Aspira Women’s Health -AWH Announces Fourth Quarter and Full Year 2025 Results - Reportify